Troluce Capital Advisors LLC Makes New Investment in Synopsys, Inc. (NASDAQ:SNPS)

Troluce Capital Advisors LLC bought a new stake in Synopsys, Inc. (NASDAQ:SNPS - Free Report) during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission. The firm bought 7,070 shares of the semiconductor company's stock, valued at approximately $3,431,000. Synopsys comprises 0.1% of Troluce Capital Advisors LLC's investment portfolio, making the stock its 14th biggest position.

Other hedge funds and other institutional investors also recently modified their holdings of the company. Whipplewood Advisors LLC purchased a new stake in Synopsys during the fourth quarter worth $33,000. Pilgrim Partners Asia Pte Ltd purchased a new position in shares of Synopsys in the 4th quarter worth $34,000. Sierra Ocean LLC acquired a new stake in Synopsys during the fourth quarter worth about $39,000. Hazlett Burt & Watson Inc. raised its holdings in shares of Synopsys by 28.6% in the 4th quarter. Hazlett Burt & Watson Inc. now owns 90 shares of the semiconductor company's stock worth $44,000 after purchasing an additional 20 shares during the period. Finally, Annis Gardner Whiting Capital Advisors LLC grew its holdings in shares of Synopsys by 50.8% during the 4th quarter. Annis Gardner Whiting Capital Advisors LLC now owns 98 shares of the semiconductor company's stock worth $48,000 after purchasing an additional 33 shares during the period. 85.47% of the stock is currently owned by hedge funds and other institutional investors.

Synopsys Stock Down 0.1%

SNPS stock traded down $0.40 during trading on Tuesday, hitting $515.61. 740,736 shares of the company's stock traded hands, compared to its average volume of 1,107,856. The stock has a fifty day moving average price of $447.85 and a two-hundred day moving average price of $489.13. Synopsys, Inc. has a 52 week low of $365.74 and a 52 week high of $624.80. The stock has a market capitalization of $79.72 billion, a price-to-earnings ratio of 35.51, a price-to-earnings-growth ratio of 3.23 and a beta of 1.16.

Analysts Set New Price Targets

Several research firms recently commented on SNPS. Mizuho cut their price target on shares of Synopsys from $650.00 to $600.00 and set an "outperform" rating on the stock in a report on Tuesday, April 15th. Bank of America decreased their price target on Synopsys from $630.00 to $560.00 and set a "buy" rating for the company in a report on Wednesday, April 16th. Wells Fargo & Company dropped their price objective on shares of Synopsys from $540.00 to $520.00 and set an "equal weight" rating on the stock in a research note on Thursday, February 27th. Stifel Nicolaus set a $550.00 target price on shares of Synopsys in a research note on Monday, April 28th. Finally, Piper Sandler dropped their target price on Synopsys from $655.00 to $653.00 and set an "overweight" rating on the stock in a research report on Thursday, February 27th. One analyst has rated the stock with a hold rating and twelve have assigned a buy rating to the company's stock. According to data from MarketBeat, the stock presently has an average rating of "Moderate Buy" and a consensus target price of $614.86.

Insider Activity

In other Synopsys news, insider Geus Aart De sold 15,705 shares of Synopsys stock in a transaction that occurred on Thursday, March 6th. The shares were sold at an average price of $444.42, for a total value of $6,979,616.10. Following the transaction, the insider now owns 116,671 shares in the company, valued at approximately $51,850,925.82. The trade was a 11.86% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which can be accessed through this hyperlink. Also, CEO Sassine Ghazi sold 11,366 shares of the company's stock in a transaction on Monday, March 3rd. The shares were sold at an average price of $463.75, for a total value of $5,270,982.50. Following the completion of the transaction, the chief executive officer now directly owns 70,922 shares in the company, valued at $32,890,077.50. This represents a 13.81% decrease in their position. The disclosure for this sale can be found here. Corporate insiders own 0.62% of the company's stock.

About Synopsys

Synopsys, Inc provides electronic design automation software products used to design and test integrated circuits. It operates in three segments: Design Automation, Design IP, and Software Integrity. The company offers Digital and Custom IC Design solution that provides digital design implementation solutions; Verification solution that offers virtual prototyping, static and formal verification, simulation, emulation, field programmable gate array (FPGA)-based prototyping, and debug solutions; and FPGA design products that are programmed to perform specific functions.